Under the collaboration Foundation Medicine will use its genomic sequencing and analytical capabilities to assess potentially relevant molec...
You must be logged in to view the whole article.
Click here if you require signing up
MorphoSys, Galapagos advance MOR106 antibody into preclinical development in inflammatory diseases
Sequenom Laboratories expands MaterniT21 PLUS test with 3 additional subchromosomal microdeletions
Nymox unveils promising efficacy findings from Phase III study of NX-1207 in BPH
Neurotrope licenses Bryostatin-1 for Niemann-Pick Type C Disease from Icahn School of Medicine
Epistem, Global Health Investment Fund join forces to launch Genedrive molecular diagnostic platform
Rosetta Genomics gains New York State final nod for kidney cancer test
Erytech recruits 1st patient in US Phase I/II trial of ERY-ASP in acute lymphoblastic leukemia
Galectin unveils dosing of 1st patient in Phase Ib melanoma study of GR-MD-02 plus Yervoy
Halozyme reinitiates recruitment, dosing in Phase II pancreatic cancer study of PEGPH20
Anacor Pharmaceuticals partners with Sandoz for commercialisation of KERYDIN in the US